This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Japan Science and Technology Agency. Active years: 2010-2016.
Company Filing History:
Years Active: 2010-2016
Title: Masayoshi Shichiri: Innovator in Angiogenesis Inhibition and Hypotensive Peptides
Introduction
Masayoshi Shichiri is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biomedical research, particularly in the development of novel therapeutic agents. With a total of 2 patents, his work focuses on innovative solutions for various health conditions.
Latest Patents
Shichiri's latest patents include the use of ansamycin antibiotics and a method for screening novel angiogenesis inhibitors. This invention provides effective and safe angiogenesis inhibitors that can be used in treating diseases such as malignant tumors and diabetic retinopathy. The active ingredients include ansamycin antibiotics like rifampicin and rifamycin SV, which have been extensively used for treating bacterial infections. The screening method allows for the detection of angiogenesis-inhibiting signals based on gene expression levels.
Another significant patent is for a cardioinhibitory and antihypertensive novel endogenous physiologically active peptide. This invention presents a peptide that exhibits potent hypotensive activity by inhibiting cardiac contractility. The peptide, consisting of 24 amino acids, shows a marked systemic hypotensive effect and has been identified through genetic database searches.
Career Highlights
Masayoshi Shichiri is affiliated with the Japan Science and Technology Agency, where he conducts his research and development activities. His work has garnered attention for its potential applications in treating various cardiovascular and angiogenesis-related diseases.
Collaborations
Shichiri collaborates with Yujiro Tanaka, contributing to the advancement of research in their respective fields. Their partnership enhances the potential for innovative discoveries and applications in biomedical science.
Conclusion
Masayoshi Shichiri's contributions to the field of biomedical research through his patents on angiogenesis inhibitors and hypotensive peptides highlight his role as an influential inventor. His work continues to pave the way for new therapeutic options in medicine.